Back

Dissecting the oncogenic mechanisms of POT1 cancer mutations through deep scanning mutagenesis

Martin, A.; Schabort, J.; Bartke-Croughan, R.; Tran, S.; Preetham, A.; Lu, R.; Ho, R.; Gao, J.; Jenkins, S.; Boyle, J.; Ghanim, G. E.; Jagota, M.; Song, Y. S.; Li, H.; Hockemeyer, D.

2024-08-19 cancer biology
10.1101/2024.08.19.608636 bioRxiv
Show abstract

Mutations in the shelterin protein POT1 are associated with diverse cancers, but their role in cancer progression remains unclear. To resolve this, we performed deep scanning mutagenesis in POT1 locally haploid human stem cells to assess the impact of POT1 variants on cellular viability and cancer-associated telomeric phenotypes. Though POT1 is essential, frame-shift mutants are rescued by chemical ATR inhibition, indicating that POT1 is not required for telomere replication or lagging strand synthesis. In contrast, a substantial fraction of clinically-validated pathogenic mutations support normal cellular proliferation, but still drive ATR-dependent telomeric DNA damage signaling and ATR-independent telomere elongation. Moreover, this class of cancer-associated POT1 variants elongates telomeres more rapidly than POT1 frame-shifts, indicating they actively drive oncogenesis and are not simple loss-of-function mutations.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.